Segment 142 Minna St.San Francisco, CA 94105415-213-2870https://segment.com Key contact Name Title Peter Reinhardt CEO SAN FRANCISCO, CA, Segment announced a $175M round of new funding. The Series D round was co-led by existing investors Accel, GV, and new investor Meritech Capital. Segment, the customer data infrastructure company, today announced a $175 million round of new […]
Archivio Categoria: venture capital funding
04
Apr
Apr
Studio Movie Grill 12404 Park Central, Suite 400Dallas, TX 75251972-388-7888https://www.studiomoviegrill.com/ Key contact Name Title Brian Schultz CEO DALLAS, TX, Studio Movie Grill announced that it has received a strategic growth investment of $100 million from TowerBrook Capital Partners. Studio Movie Grill ("SMG" or "the Company") today announced that it has received a strategic growth investment […]
Tioga Medical Campbekk, CAhttp://www.tiogahealth.org/ Key contact Name Title Mike Dineen President & CEO CAMPBELL, CA, Tioga Medical, a newly formed Shifamed portfolio company, announced today the closing of its Series A preferred stock financing, raising a total of $15M. Tioga Medical was founded to provide physicians and patients with an elegant transcatheter valve replacement experience […]
03
Apr
Apr
Dyne Therapeutics 400 Technology Square, 10th FloorCambridge, MA 02139https://www.dyne-tx.com/ Key contact Name Title Romesh Subramanian CEO CAMBRIDGE, MA, New biotechnology company pioneering targeted therapies for patients with serious muscle diseases, launched today with a $50 million Series A. Dyne Therapeutics, a new biotechnology company pioneering targeted therapies for patients with serious muscle diseases, launched today […]
GIBLIB 3470 Wilshire Blvd.Los Angeles, CA 92866https://giblib.com/ Key contact Name Title Brian Conyer CEO LOS ANGELES, CA, Streaming media platform has closed $2,500,000 in seed funding. GIBLIB, the streaming media platform offering the largest library of on-demand medical lectures and surgical videos in 4K and 360-degree virtual reality, has closed $2,500,000 in seed funding. The […]
03
Apr
Apr
Affirm PO Box 2854�San Francisco, CA 94126415-535-8050https://www.affirm.com Key contact Name Title Max Levchin CEO SAN FRANCISCO, CA, Financial technology company has raised a $300 million series F round of funding led by Thrive Capital. Affirm, the financial technology company founded by entrepreneur Max Levchin to provide honest financial products that improve lives, today announced it […]
03
Apr
Apr
Deepwatch 146 2nd Street North, Suite 107Saint Petersburg, FL 33701855-303-3033https://www.deepwatch.com/ Key contact Name Title Charlie Thomas CEO ST. PETERSBURG, FL, Leading provider of intelligence-driven managed security services, has closed a $23M Series A funding round led by ABS Capital Partners. deepwatch, a leading provider of intelligence-driven managed security services, announced the closing of a USD […]
02
Apr
Apr
SpringWorks Therapeutics 100 Washington Blvd.Stamford, CT 06902203-883-9490https://www.springworkstx.com/ Key contact Name Title Saqib Islam CEO STAMFORD, CT, SpringWorks Therapeutics announced the closing of a $125 million Series B preferred stock financing led by Perceptive Advisors. SpringWorks Therapeutics, Inc. (the "Company"), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and […]
02
Apr
Apr
EzCater 101 Arch StreetBoston, MA 02108800-488-1803https://www.ezcater.com/ Key contact Name Title Stefania Mallett CEO BOSTON, MA, ezCater, the world's largest online catering marketplace, today announced that it has raised a $150 million Series D-1 investment round The round was co-led by Lightspeed Venture Partners and GIC. ezCater will use the funds to continue its global expansion […]
Aura Biosciences 85 Bolton StreetCambridge, MA 02140617-871-1241www.aurabiosciences.com Key contact Name Title Elisabet de los Pinos CEO CAMBRIDGE, MA, Aura Biosciences today announced that it closed a $40 million Series D financing. Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that it closed a $40 million Series D […]